|
HS Code |
117120 |
| Product Name | 4-Methylphenyl-L-Alanine |
| Synonyms | L-4-Methylphenylalanine |
| Chemical Formula | C10H13NO2 |
| Molecular Weight | 179.22 g/mol |
| Cas Number | 2113-53-1 |
| Appearance | White to off-white powder |
| Melting Point | 261-263 °C (dec.) |
| Solubility In Water | Slightly soluble |
| Optical Rotation | [α]20/D +20 to +24° (c=1, H2O) |
| Purity | Typically ≥98% |
| Storage Conditions | Store at 2-8°C |
| Pka | 2.34 (carboxyl), 9.69 (amino) |
| Inchi Key | ORZNHKOJZWBTQX-UHFFFAOYSA-N |
| Smiles | CC1=CC=C(C=C1)CC(C(=O)O)N |
As an accredited 4-Methylphenyl-L-Alanine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A white, sealed 100g bottle labeled "4-Methylphenyl-L-Alanine, ≥99% purity," featuring hazard symbols and batch identification. |
| Shipping | 4-Methylphenyl-L-Alanine is shipped in sealed, chemical-resistant containers to maintain product integrity and prevent contamination. It is packed with cushioning materials, labeled according to regulatory requirements, and accompanied by a Safety Data Sheet (SDS). The shipment is handled by certified carriers, complying with all applicable national and international transport regulations. |
| Storage | 4-Methylphenyl-L-alanine should be stored in a tightly closed container, protected from light and moisture. Keep in a cool, dry, well-ventilated area, ideally at 2–8°C (refrigerated). Avoid exposure to heat, incompatible materials, and prolonged air contact. Ensure the workspace is free from sources of ignition, and practice good chemical hygiene to maintain stability and prevent degradation. |
Applications of 4-Methylphenyl-L-Alanine in Industrial ManufacturingWe manufacture 4-Methylphenyl-L-Alanine for regulated, knowledge-driven sectors. This material supports advanced chemical synthesis and finished product formulations across pharmaceutical, biochemical, specialty peptide, and diagnostic reagent industries. Outlined below are application scenarios with specific regulatory, formulation, process, and product details. 1. Peptide API Manufacturing4-Methylphenyl-L-Alanine functions as a protected amino acid during the solid-phase synthesis of peptide-based active pharmaceutical ingredients. In oncology, metabolic, or anti-infective drug development, peptide chemists incorporate this amino acid at designated sequence positions during chain elongation cycles. The downstream process relies on controlled deprotection, coupling, and purification to achieve required peptide purity per regulatory submissions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Amino Acid Derivative Production for Research BiochemistryWe supply 4-Methylphenyl-L-Alanine to contract and in-house biochemical synthesis laboratories focused on developing specialty amino acid derivatives. These derivatives serve as enzyme substrates, receptor ligands, or standards for chiral analytical studies. Downstream requests often specify requirements for ultra-low metal and bioburden backgrounds, matching for isotopic labeling, and custom salt forms. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Pharmaceutical Impurity ProfilingPharmaceutical quality laboratories use 4-Methylphenyl-L-Alanine in the targeted synthesis of process-related impurities and degradation products for reference standard generation. This supports regulatory filings and ongoing GMP lot release analytics for peptide APIs with aromatic, methylated side chains. Continuous supply enables batch tracking and impurity mapping for stability studies. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Diagnostic Peptide SynthesisIVD and medical diagnostic kit manufacturers utilize our material in custom peptide antigen synthesis for ELISA, CLIA, and other assay formats. Inclusion as a marked residue allows epitope mapping, antibody specificity screening, and development of kits targeting disease biomarkers. Quality routines define the incoming acceptance and in-process controls for reproducibility and sterility. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Methylphenyl-L-Alanine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemists often talk about foundations, and for us producing 4-Methylphenyl-L-Alanine, it’s much more than a necessary step in a synthesis pathway—it’s about commitment to both consistency and genuine reliability. Our teams have been handling aromatic amino acids long enough to appreciate how subtle changes in synthesis and purification can cause headaches further down the line for customers. We know the satisfaction in opening a fresh bottle and seeing the fine, white solid you expect—and the frustration when suppliers cut corners or batch variation shows up unannounced. Producing this amino acid, we rely on processes built and tuned over years, not overnight experiments.
In most catalogs and technical sheets, 4-Methylphenyl-L-Alanine gets reduced to a chemical formula—C10H13NO2—and a line about purity above 99%. Those numbers matter, but they don’t tell what goes into achieving them batch after batch. Achieving reliable optical rotation and minimizing impurities like diketopiperazines or racemization byproducts is not just a matter of careful monitoring during crystallization and post-process drying. It takes truly stable access to starting materials, controls over storage and handling of reagents, and process operators who recognize the difference between a good lot and a great one. We deliver the L-enantiomer every time; enantiopurity isn’t just a footnote in our reports, it’s the baseline for every lot we release.
Among substituted phenylalanine derivatives, the para-methyl group on 4-Methylphenyl-L-Alanine brings a delicate balance. This methyl isn’t just for show—it influences both steric properties and hydrophobicity, which can trickle down into activity and selectivity when used as a building block in pharmaceuticals or custom peptides. If you’ve worked with straight phenylalanine, the para-methyl derivative’s difference in solubility and reactivity in peptide couplings shows up fast. For researchers focusing on enzyme inhibitors, neurotransmitter research, or structure-activity relationship mapping, this compound gives new levers to pull on. We manufacture 4-Methylphenyl-L-Alanine, 4-Fluorophenyl-L-Alanine, and 4-Chlorophenyl-L-Alanine—each brings its own quirks in process and application, but customers usually circle back to 4-Methylphenyl-L-Alanine for the stability and predictable performance it offers, especially in solid-phase peptide synthesis.
We don’t see ourselves as distant suppliers. Most of our employees have a foot in the lab or started behind a bench, so we recognize that the results in research depend on every gram of material’s integrity. Handling this amino acid from kilograms to multi-ton scale, we encountered the same issues researchers do—batch-to-batch purity, unwanted side-products, aging under long-term storage. Each lot isn’t treated as just another production run; we inspect for issues like elevated aldehyde content, early signs of acid-catalyzed degradation, or even packaging flaws. Smaller suppliers sometimes blend older material to meet specs, which undermines trust. Instead, we built in features like moisture-guard packaging and rapid-labeling so returns and recalls don’t happen. Only consistently handled batches reach our customers.
Working directly with peptide chemists, we’ve heard complaints about contamination with trace metals and persistent issues from carryover solvents in dry stocks coming from other producers. These issues have direct effects—traces of metals, for instance, can poison downstream catalysts or N-alkylation reactions. Large pharmaceutical processors didn’t just want purity, they cared about what’s not reported on the certificate, like trace water content or the presence of endotoxins. Over the years, we added inline water activity measurement and improved filtration steps to keep even the hard-to-detect contaminants in check. We test tighter than external standards, and when customers call out new requirements, we factor that into the next process cycle rather than treating it as an exception. Continuous adjustments to pH controls, drying times, and even packaging shape these manufacturing advances.
Some products change the way you work with chemistry. 4-Methylphenyl-L-Alanine, when produced with attention to detail, slots straight into demanding synthetic sequences—no extra washing needed, no pre-treatment to remove “mystery” peaks in NMR spectra, no ambiguity about protected groups carrying over from synthesis. Our L-form meets the chiral purity needed for custom peptide synthesis and drug research, where even a trace of the wrong enantiomer can derail an entire sequence. For scale-up, the reproducibility of our material’s physical properties—such as density, melting range, and flow—saves time and avoids the need to reoptimize conditions for each lot. We actively check physical and chemical traits after every process improvement, making sure changes don’t ripple into unexpected performance shifts.
Refusing to treat each batch as interchangeable, we design feedback into our production cycles. A customer working in CNS research once flagged an impurity during LC-MS monitoring at low nanogram levels. Some might have brushed it off as trace contamination; we took it as a signal to review upstream steps, adjusting both the choice of precursor solvents and crystallization queue. Process history and paper trails aren’t bureaucracy—they’re the foundation for learning and improving. We have in-house analysts familiar with both routine and edge-case testing, so we can confirm what’s present and why. Most distribution companies can't spot these issues until customers complain—manufacturing internally lets us take accountability and share solutions transparently.
We control both synthesis and scale, relying on vertically integrated access to precursors. That means our pricing holds steady even as global disruptions shift the cost of upstream chemicals. It’s not always easy—building redundancy for critical reagents and setting up in-house purification trains for starter materials cost time and resources. These steps proved crucial during international shipping bottlenecks and feedstock shortages. Customers counting on deliveries for ongoing trials or production runs avoided headaches thanks to this stability. Price isn’t just a number for us; it reflects years of process investment and hands-on management. When researchers plan a six- or twelve-month campaign, they bank on both the budget and the uninterrupted supply that comes from writing the check directly to the manufacturer, not a string of middlemen.
Certifications matter but rarely tell the whole story. Auditors and inspectors know the difference between a perfectly kept paperwork trail and real operational discipline. We open our doors to customer audits, not just as a reassurance but because feedback sharpens our own expectations and standards. More than one client started with a basic audit and switched their entire order book after seeing our solvent handling stations, water testing lines, and system redundancies for stocking hazardous intermediates. Building safeguards for accidental cross-contamination, maintaining records on every pressure reactor batch, and cycling QC teams across product lines gives us both depth and breadth in maintaining standards.
Researchers in medicinal chemistry reach for 4-Methylphenyl-L-Alanine during peptide chain elongation, SAR studies, and screening analogs for enzyme targeting. Some projects integrate it into modified antimicrobial peptides; others push on boundaries in neurotransmitter mimetics. Analytical teams ask for sharply defined melting points and IR signatures to confirm absence of contamination from side-products. End customers rarely see the raw material’s journey, but when a project advances to clinic or patent stage, the viability and purity of the original building blocks matter. Years of consistent supply allowed one of our partners to scale from early discovery right through to GMP validation without switching suppliers or validating new sources—a benefit that often gets overlooked until sudden interruptions force an expensive change in direction.
Many manufacturing stories stop at the shipping dock. Our relationship doesn’t end when the truck leaves the gate. Troubleshooting syntheses together, receiving unexpected stability queries, and responding to sudden scaling requests—these conversations shape our ongoing work. An oncology group working with N-methylated analogs once ran into catalytic poisoning traced back to off-the-shelf amino acids. We walked their team through troubleshooting and sent material aliquots from in-process controls so they could pinpoint the issue—an extra level of support beyond transactional supply. Shared experience informs better practice on both sides; the same goes for developing new handling instructions or adjusting batch sizes to match actual project flows, not broad commercial guesswork.
People often romanticize process improvement as sudden leaps, but in chemical manufacturing, real gains come from dozens of incremental adjustments. We track everything from step yields and tailing losses to operator variance at every shift handover. When a trend appears—such as marginal shifts in dry weight or slight yellowing after prolonged storage—we follow the thread, revisiting SOPs and sometimes retraining teams. Manufacturing 4-Methylphenyl-L-Alanine this way pays off as stability and purity profiles improve not with big overhauls, but with sustained attention. Many external suppliers rely on their own set processes and resist change; as both manufacturer and direct supplier, our approach stays nimble, prioritizing product improvements that keep pace with our customers’ evolving requirements.
Every line in a process log tells a story. In earlier years, we chased issues with consistently removing unreacted starting material during post-reaction washing, which led to subtle carryover peaks in chromatographic profiles. Simple column changes didn’t cut it; realresolution came from pairing mechanical upgrades with tighter temperature and pH ramping protocols. Another challenge surfaced with managing electrostatic charge during powder handling, a real problem for high-throughput filling systems, causing lot-to-lot clumping or packing inefficiency. Installing enhanced dust filtration, regulating humidity, and switching conveyors worked over time, reducing lost product and batch deviations. In-house solutions often outpace outside consultant fixes because feedback is direct from the people working daily on the lines.
Regulatory shifts introduce new hurdles for international supply chains. While some chemical firms scramble to adapt on paper, our integrated production helps us address region-specific demands for purity, traceability, and documentation. European customers often request not just GMP alignment but details on residual solvent spectra. For research export to Asia, customs sometimes trigger secondary documentation for origin and handling. We manage these factors directly—no hand-offs, no documentation coming from distant resellers. This transparency keeps researchers on both sides of the ocean moving forward, not getting stuck in red tape or chasing missing certificates. As standards tighten or new harmonizations emerge, we’ve already adapted—sometimes years ahead—so customers downstream don’t get caught by regulatory holds or surprise paperwork.
Modern chemistry must pay more than lip service to environmental and operator safety. Early on, we transitioned away from solvents with serious emissions profiles, retooled exhaust scrubbers, and retrained staff on spill protocols specific to aromatic amino acid production. Time and investment spent on better containment systems, solvent reclamation, and automated transfer stations isn’t “optional cost”—it becomes embedded in product quality and long-term staff experience. Environmental authorities have shifted requirements on effluent, so upgrades to our water treatment align with anticipated future guidelines, not just minimums on the books. Our team’s hands-on work drives improvements, which pays off both for customers and everyone at the plant every day.
Not every lab or company needs the same thing from 4-Methylphenyl-L-Alanine. We learned that the hard way handling custom derivatives where even subtle changes in particle size or trace impurity profile shift application results. Starting or scaling a synthesis line, moving to continuous production, or tightening analytical requirements—each step brings new pressures, new feedback. Our job as the original manufacturer is to anticipate shifts, share what we’ve learned, and stay accessible to both established and emerging innovators. No substitute exists for direct, clear communication between users and producers. We treat each order, each sample request, and each technical call as a chance to adapt, refine, and deliver a product that works—every time, from grams to tons.